These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9926153)

  • 1. Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation.
    Palmqvist M; Pettersson K; Sjöstrand M; Andersson B; Löwhagen O; Lötvall J
    Respir Med; 1998 Oct; 92(10):1223-30. PubMed ID: 9926153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen.
    Alvarez MJ; Echechipía S; García B; Tabar AI; Martín S; Rico P; Olaguibel JM
    Clin Exp Allergy; 2002 Nov; 32(11):1574-82. PubMed ID: 12569977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced late asthmatic response by repeated low-dose allergen exposure.
    Palmqvist M; Cui ZH; Sjöstrand M; Lindén A; Lötvall J
    Eur Respir J; 2001 May; 17(5):872-80. PubMed ID: 11488319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
    Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
    J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.
    Pavord I; Mudassar T; Bennett J; Wilding P; Knox A
    Eur Respir J; 1996 Feb; 9(2):217-9. PubMed ID: 8777954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
    Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma.
    Lopuhaä CE; Out TA; Jansen HM; Aalberse RC; van der Zee JS
    Clin Exp Allergy; 2002 Dec; 32(12):1720-7. PubMed ID: 12653162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhaled prostaglandin E2 on allergen-induced asthma.
    Pavord ID; Wong CS; Williams J; Tattersfield AE
    Am Rev Respir Dis; 1993 Jul; 148(1):87-90. PubMed ID: 8317820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
    Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
    Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No signs of activity markers in peripheral blood despite increased bronchial reactivity after repeated low-dose allergen exposure.
    Roquet A; Lagging E; Ihre E; van Hage-Hamsten M; Halldén G; Härfast B; Zetterström O
    APMIS; 1998 Feb; 106(2):293-9. PubMed ID: 9531962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low-dose allergen challenge in atopic asthmatics.
    Gauvreau GM; Sulakvelidze I; Watson RM; Inman MD; Rerecich TJ; O'Byrne PM
    Clin Exp Allergy; 2000 Sep; 30(9):1235-43. PubMed ID: 10971469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen.
    Swystun VA; Bhagat R; Kalra S; Jennings B; Cockcroft DW
    J Allergy Clin Immunol; 1998 Sep; 102(3):363-7. PubMed ID: 9768574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose endotoxin in allergic asthmatics: effect on bronchial and inflammatory response to cat allergen.
    Sohy C; Pons F; Casset A; Chesnard MP; Lieutier-Colas F; Meyer P; Pauli G; de Blay F
    Clin Exp Allergy; 2006 Jun; 36(6):795-802. PubMed ID: 16776681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.
    Jónasson G; Carlsen KH; Blomqvist P
    Eur Respir J; 1998 Nov; 12(5):1099-104. PubMed ID: 9864004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R; Swystun VA; Cockcroft DW
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.